04/17/2024
8:38 PM | Outlook Therapeutics, Inc. (Subject)
Outlook Therapeutics (Subject)
Syntone Ventures LLC (Filed by)
| Form SC 13D/A | |
04/17/2024
7:21 PM | Outlook Therapeutics, Inc. (Issuer)
Outlook Therapeutics (Issuer)
Syntone Ventures LLC (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/16/2024
4:21 PM | Outlook Therapeutics, Inc. (Filer)
Outlook Therapeutics (Filer)
| Form D
Notice of Exempt Offering of Securities | |
04/15/2024
3:53 PM | Outlook Therapeutics, Inc. (Filer)
Outlook Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/12/2024
3:27 PM | Outlook Therapeutics, Inc. (Filer)
Outlook Therapeutics (Filer)
| Form 424B5 | |
04/07/2024
11:15 PM | Outlook Therapeutics, Inc. (Filer)
Outlook Therapeutics (Filer)
| Form EFFECT | |
04/02/2024
3:15 PM | Outlook Therapeutics, Inc. (Filer)
Outlook Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
|
04/01/2024
11:15 PM | Outlook Therapeutics, Inc. (Filer)
Outlook Therapeutics (Filer)
| Form EFFECT | |
04/01/2024
3:53 PM | Outlook Therapeutics, Inc. (Filer)
Outlook Therapeutics (Filer)
| Form 424B3 | |
03/29/2024
1:16 PM | Outlook Therapeutics, Inc. (Filer)
Outlook Therapeutics (Filer)
| Form D
Notice of Exempt Offering of Securities | |
03/29/2024
9:39 AM | Haddadin Yezan Munther (Reporting)
Outlook Therapeutics, Inc. (Issuer)
Outlook Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/28/2024
3:00 PM | Outlook Therapeutics, Inc. (Subject)
Outlook Therapeutics (Subject)
TANG CAPITAL PARTNERS LP (Filed by)
| Form SC 13G | |
03/26/2024
3:20 PM | Outlook Therapeutics, Inc. (Filer)
Outlook Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/25/2024
3:11 PM | Outlook Therapeutics, Inc. (Filer)
Outlook Therapeutics (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
03/22/2024
4:00 PM | KENYON LAWRENCE A (Reporting)
Outlook Therapeutics, Inc. (Issuer)
Outlook Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/22/2024
4:00 PM | Evanson Jeff (Reporting)
Outlook Therapeutics, Inc. (Issuer)
Outlook Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/22/2024
4:00 PM | Outlook Therapeutics, Inc. (Issuer)
Outlook Therapeutics (Issuer)
TRENARY C RUSSELL III (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/20/2024
4:24 PM | GMS Ventures & Investments (Filed by)
Outlook Therapeutics, Inc. (Subject)
Outlook Therapeutics (Subject)
| Form SC 13D/A | |
03/20/2024
4:20 PM | GMS Ventures & Investments (Reporting)
Outlook Therapeutics, Inc. (Issuer)
Outlook Therapeutics (Issuer)
Sukhtian Ghiath M. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/18/2024
4:14 PM | Outlook Therapeutics, Inc. (Filer)
Outlook Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/11/2024
3:43 PM | Evanson Jeff (Reporting)
Outlook Therapeutics, Inc. (Issuer)
Outlook Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/08/2024
3:18 PM | Huang Andong (Reporting)
Outlook Therapeutics, Inc. (Issuer)
Outlook Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/08/2024
5:59 AM | Outlook Therapeutics, Inc. (Filer)
Outlook Therapeutics (Filer)
| Form DEF 14A | |
02/08/2024
6:00 AM | Outlook Therapeutics, Inc. (Filer)
Outlook Therapeutics (Filer)
| Form ARS | |
01/24/2024
5:02 AM | Outlook Therapeutics, Inc. (Filer)
Outlook Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/22/2023
4:00 PM | Outlook Therapeutics, Inc. (Filer)
Outlook Therapeutics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
12/06/2023
4:00 PM | Outlook Therapeutics, Inc. (Filer)
Outlook Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/02/2023
7:12 AM | Outlook Therapeutics, Inc. (Filer)
Outlook Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/20/2023
4:00 PM | Outlook Therapeutics, Inc. (Filer)
Outlook Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/06/2023
7:16 AM | Gangolli Julian S (Reporting)
Outlook Therapeutics, Inc. (Issuer)
Outlook Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/05/2023
4:13 PM | Auffarth Gerd (Reporting)
Outlook Therapeutics, Inc. (Issuer)
Outlook Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/05/2023
4:14 PM | Huang Andong (Reporting)
Outlook Therapeutics, Inc. (Issuer)
Outlook Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/05/2023
4:15 PM | Haller Julia A (Reporting)
Outlook Therapeutics, Inc. (Issuer)
Outlook Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/05/2023
4:05 PM | HILZINGER KURT J (Reporting)
Outlook Therapeutics, Inc. (Issuer)
Outlook Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/05/2023
4:06 PM | Outlook Therapeutics, Inc. (Issuer)
Outlook Therapeutics (Issuer)
Sukhtian Faisal Ghiath (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/05/2023
4:07 PM | Haddadin Yezan Munther (Reporting)
Outlook Therapeutics, Inc. (Issuer)
Outlook Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/30/2023
5:21 AM | Outlook Therapeutics, Inc. (Filer)
Outlook Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/27/2023
11:15 PM | Outlook Therapeutics, Inc. (Filer)
Outlook Therapeutics (Filer)
| Form EFFECT | |
08/25/2023
3:31 PM | Outlook Therapeutics, Inc. (Filer)
Outlook Therapeutics (Filer)
| Form 424B5 | |
08/14/2023
4:19 PM | Outlook Therapeutics, Inc. (Filer)
Outlook Therapeutics (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
05/16/2023
6:10 AM | Outlook Therapeutics, Inc. (Filer)
Outlook Therapeutics (Filer)
| Form 424B5 | |
This Apple-like Innovator is Revolutionizing Healthcare (Ad) AI has infiltrated so many sectors, it's sent the demand for AI-friendly GPU computer chips rocketing.
Nvidia has gone up more than 3x in the past year. It is now valued well over $2 trillion, making it one of the largest companies in the world. Click here to learn more about the booming eHealth industry |
05/16/2023
5:01 AM | Outlook Therapeutics, Inc. (Filer)
Outlook Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
